File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Dual-tracer PET/CT for the differential diagnosis of small liver nodules (1-2 cm) in cirrhosis: Early HCC or dysplastic nodule?
| Title | Dual-tracer PET/CT for the differential diagnosis of small liver nodules (1-2 cm) in cirrhosis: Early HCC or dysplastic nodule? |
|---|---|
| Authors | |
| Issue Date | 2012 |
| Publisher | Society of Nuclear Medicine. The Journal's web site is located at http://jnm.snmjournals.org |
| Citation | The 2012 Annual Meeting of the Society of Nuclear Medicine (SNM), Miami Beach, FL., 9-13 June 2012. In The Journal of Nuclear Medicine, 2012, v. 53 suppl. 1, no. 566 How to Cite? |
| Abstract | Objectives: Contrast CT was less accurate in the differentiation of small liver nodules (1-2 cm), particularly in severe cirrhosis. We evaluated the accuracy of dual-tracer (11C-acetate: ACT and 18F-FDG: FDG) PET/CT for the differentiation between small HCC and dysplastic nodules in cirrhotic liver as compared to contrast CT.
Methods: Patients with cirrhosis and HCC 1-2 cm confirmed by postoperative pathology after liver transplant or hepatectomy were included if they had both preoperative dual-tracer PET/CT and contrast CT within 1 month. For the diagnosis of HCC, dual-tracer PET/CT was reviewed qualitatively by 3 nuclear medicine physicians in consensus, supported by lesion-to-liver SUV>1.20 (either tracer). Diagnosis by CT was made by 2 radiologists based on the triple-phase pattern of arterial contrast enhancement and washout during portal venous or delayed phase. Each lesion was compared with pathology in terms of diagnosis, size and location. Statistics were analysed by Chi-square and student t tests.
Results: 20 patients (M: 15, F: 5, mean: 54±9.2y) with 23 small HCC lesions and 12 dysplastic nodules were identified by postoperative pathology. The mean size of small HCC was 1.6±0.35 cm, dysplastic nodules 1.5±0.34 cm (p>0.05). ACT PET identified 20/23 (87.0%) small HCC lesions while FDG detected 4/23 (17.4%) with dual-tracer sensitivity of 91.3% (21/23). ACT and dual-tracer PET were significantly more sensitive for the diagnosis of early HCC than contrast CT (10/23: 43.5%), with both p<0.05. Of the 23 small HCC lesions, 15 (65.2%) were well and 8 (34.8%) were moderately differentiated. Both FDG and ACT were true negative for all dysplastic nodules (specificity: 100%); while contrast CT misdiagnosed 4 dysplastic nodules as early HCC (specificity: 66.7%).
Conclusions: Dual-tracer PET/CT was superior to contrast CT for differentiating small HCC from dysplastic nodules (1-2 cm) in cirrhotic livers. ACT was the PET tracer essential for early HCC detection |
| Description | Oncology: Clinical Diagnosis: GI-Colorectal & Liver |
| Persistent Identifier | http://hdl.handle.net/10722/165648 |
| ISSN | 2021 Impact Factor: 11.082 2020 SCImago Journal Rankings: 2.319 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ho, CL | en_US |
| dc.contributor.author | Chen, SR | en_US |
| dc.contributor.author | Cheung, TT | en_US |
| dc.contributor.author | Leung, YL | en_US |
| dc.contributor.author | Cheng, TKC | en_US |
| dc.contributor.author | Wong, KN | en_US |
| dc.date.accessioned | 2012-09-20T08:21:40Z | - |
| dc.date.available | 2012-09-20T08:21:40Z | - |
| dc.date.issued | 2012 | en_US |
| dc.identifier.citation | The 2012 Annual Meeting of the Society of Nuclear Medicine (SNM), Miami Beach, FL., 9-13 June 2012. In The Journal of Nuclear Medicine, 2012, v. 53 suppl. 1, no. 566 | en_US |
| dc.identifier.issn | 0161-5505 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/165648 | - |
| dc.description | Oncology: Clinical Diagnosis: GI-Colorectal & Liver | - |
| dc.description.abstract | Objectives: Contrast CT was less accurate in the differentiation of small liver nodules (1-2 cm), particularly in severe cirrhosis. We evaluated the accuracy of dual-tracer (11C-acetate: ACT and 18F-FDG: FDG) PET/CT for the differentiation between small HCC and dysplastic nodules in cirrhotic liver as compared to contrast CT. Methods: Patients with cirrhosis and HCC 1-2 cm confirmed by postoperative pathology after liver transplant or hepatectomy were included if they had both preoperative dual-tracer PET/CT and contrast CT within 1 month. For the diagnosis of HCC, dual-tracer PET/CT was reviewed qualitatively by 3 nuclear medicine physicians in consensus, supported by lesion-to-liver SUV>1.20 (either tracer). Diagnosis by CT was made by 2 radiologists based on the triple-phase pattern of arterial contrast enhancement and washout during portal venous or delayed phase. Each lesion was compared with pathology in terms of diagnosis, size and location. Statistics were analysed by Chi-square and student t tests. Results: 20 patients (M: 15, F: 5, mean: 54±9.2y) with 23 small HCC lesions and 12 dysplastic nodules were identified by postoperative pathology. The mean size of small HCC was 1.6±0.35 cm, dysplastic nodules 1.5±0.34 cm (p>0.05). ACT PET identified 20/23 (87.0%) small HCC lesions while FDG detected 4/23 (17.4%) with dual-tracer sensitivity of 91.3% (21/23). ACT and dual-tracer PET were significantly more sensitive for the diagnosis of early HCC than contrast CT (10/23: 43.5%), with both p<0.05. Of the 23 small HCC lesions, 15 (65.2%) were well and 8 (34.8%) were moderately differentiated. Both FDG and ACT were true negative for all dysplastic nodules (specificity: 100%); while contrast CT misdiagnosed 4 dysplastic nodules as early HCC (specificity: 66.7%). Conclusions: Dual-tracer PET/CT was superior to contrast CT for differentiating small HCC from dysplastic nodules (1-2 cm) in cirrhotic livers. ACT was the PET tracer essential for early HCC detection | - |
| dc.language | eng | en_US |
| dc.publisher | Society of Nuclear Medicine. The Journal's web site is located at http://jnm.snmjournals.org | - |
| dc.relation.ispartof | The Journal of Nuclear Medicine | en_US |
| dc.title | Dual-tracer PET/CT for the differential diagnosis of small liver nodules (1-2 cm) in cirrhosis: Early HCC or dysplastic nodule? | en_US |
| dc.type | Conference_Paper | en_US |
| dc.identifier.email | Cheung, TT: cheung68@hku.hk | en_US |
| dc.identifier.hkuros | 211260 | en_US |
| dc.identifier.volume | 53 | en_US |
| dc.identifier.issue | suppl. 1 | en_US |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 0161-5505 | - |